Sign inJoin waitlistJoin the waitlist

David VanderWeele

Associate Professor · Feinberg School of Medicine

Credentials: · · · ·

History

Feinberg School of Medicine
Present

University of Chicago
Until 2013
University of Chicago
Until 2009
University of Chicago Pritzker School of Medicine
2007

Research

Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations
Journal for ImmunoTherapy of Cancer · 2018 · 233 citations
Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells
Blood · 2009 · 175 citations
Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance
Cancer Research · 2003 · 151 citations

Maha Hussain
13 papers
Fatima Karzai
9 papers
Ravi Madan
7 papers
Alicia Morgans
6 papers
Charles Rudin
6 papers
Gladell Paner
6 papers
WD
William Dahut
6 papers
Ismail Turkbey
5 papers
James Gulley
5 papers
Maria Merino
5 papers
Russell Szmulewitz
5 papers
Peter Choyke
4 papers

Clinical trials

FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial
Principal investigator · Recruiting · Phase 2
Northwestern University
2024–2028
Neoadjuvant Androgen Deprivation, Darolutamide, and Ipatasertib in Men With Localized, High Risk Prostate Cancer
Principal investigator · Terminated · Phase 1, Phase 2
David VanderWeele
2021–2022
Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer
Principal investigator · Active not recruiting · Phase 4
Northwestern University
2017–2029
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2025–2037